Industries
Politics & Economics
Newsletters
Sign in
Subscribe
Drugmakers
Vaccines
More Than Half of U.S. Voters Say They Plan to Get New COVID-19 Boosters This Year
September 15, 2023
COVID-19
After Slow Start, States Are Flush With COVID-19 Antiviral Pills. But Federal Data Shows Some Are Slow to Give Them Out
June 23, 2022
Vaccines
2 in 3 Democrats and 2 in 5 Republicans Back Proposal to Waive COVID-19 Vaccine Patent Rights
February 9, 2022
Drugmakers
Incoming PhRMA Chair Expects Drugmakers to Face ‘Some Pain’ in 2022 Amid Reform and Efforts to Rebuild Patient Trust
January 25, 2022
Drugmakers
Clinical Trials Are Slow and Expensive. Industry Leaders Want That to Change in 2022
December 21, 2021
COVID-19
The FDA Is Expected to Authorize COVID-19 Antiviral Pills. 3 in 4 Adults Say They’d Take Them if They Got Sick
November 29, 2021
Drugmakers
As Threat of Antibiotic Resistance Mounts, Biotechs Are Running Out of Cash and Time
September 5, 2019
Drugmakers
In Oklahoma, A Warning for Proponents of Value-Based Pharma Payment
February 6, 2019
Drug Pricing
As Drug Prices Soar, Policymakers Eye Dose of Government Intervention
December 20, 2018
